Drug Profile
Research programme: oral stem cell mobiliser - ExCellThera
Alternative Names: ECT 004Latest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Unknown
- Developer ExCellThera
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stem cell mobilisation
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for preclinical development in Stem-cell-mobilisation in Canada (PO)
- 01 Dec 2017 Preclinical trials in Stem cell mobilisation in Canada (PO) (ExCellThera pipeline, December 2017)